Ogawa H, Yasue H, Oshima S, Ogata Y, Numata Y, Fujimoto K, Imoto N, Saito T, Hokamura Y, Takahashi T
Division of Cardiology, Kumamoto University School of Medicine, Japan.
Jpn Circ J. 1995 Oct;59(10):663-72. doi: 10.1253/jcj.59.663.
Coronary recanalization rate and infarct size were compared between 2 different methods of intravenously administering recombinant tissue-type plasminogen activator (rt-PA) 41.4 mg; 1) an initial bolus dose of 30% followed by infusion of the remainder over 60 min (30% group), and an initial bolus dose of 10% followed by infusion of the remainder over 60 min (10% group). Thirty min after beginning rt-PA infusion, the coronary recanalization rate was higher in the 30% group than in the 10% group (82.9% (34/41) vs 53.7% (22/41), p < 0.01). The peak creatine kinase and peak creatine kinase-MB levels were lower in the 30% group than in the 10% group. We conclude that a higher initial bolus dose of rt-PA gives a higher rate of recanalization of the infarct-related artery at the very early phase, and probably leads to a smaller infarct size.
比较了两种不同方法静脉注射41.4毫克重组组织型纤溶酶原激活剂(rt-PA)后的冠状动脉再通率和梗死面积;1)初始推注剂量为30%,其余剂量在60分钟内输注(30%组),以及初始推注剂量为10%,其余剂量在60分钟内输注(10%组)。开始rt-PA输注30分钟后,30%组的冠状动脉再通率高于10%组(82.9%(34/41)对53.7%(22/41),p<0.01)。30%组的肌酸激酶峰值和肌酸激酶-MB峰值水平低于10%组。我们得出结论,较高的rt-PA初始推注剂量在极早期可使梗死相关动脉的再通率更高,并且可能导致梗死面积更小。